
The treatment is to protect children under two years of age from respiratory syncytial virus

Over 240 million people worldwide live with chronic hepatitis B

The new three-year agreement builds on an existing two-year relationship

Quotient’s somatic genomics platform technology will be used to develop the treatment

PH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide

RSV affects approximately 64 million people around the world each year

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

Symptoms of COPD include breathlessness, persistent cough and frequent chest infections

The pharma company will invest more than $70bn in the US to boost production and innovation

Cidara’s long-acting viral flu drug showed significant protection in phase 2 results

Merck will take full control of developing MK-8690, an investigational monoclonal antibody candidate

The funding will support late-stage clinical development of the investigational antibody-drug conjugate